vs
Side-by-side financial comparison of MEDICAL PROPERTIES TRUST INC (MPW) and TRIMAS CORP (TRS). Click either name above to swap in a different company.
MEDICAL PROPERTIES TRUST INC is the larger business by last-quarter revenue ($270.3M vs $256.5M, roughly 1.1× TRIMAS CORP). TRIMAS CORP runs the higher net margin — 31.9% vs 6.5%, a 25.3% gap on every dollar of revenue. On growth, MEDICAL PROPERTIES TRUST INC posted the faster year-over-year revenue change (16.6% vs 3.8%). Over the past eight quarters, TRIMAS CORP's revenue compounded faster (3.3% CAGR vs -0.2%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.
MPW vs TRS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.3M | $256.5M |
| Net Profit | $17.6M | $81.7M |
| Gross Margin | 95.8% | 12.8% |
| Operating Margin | 9.7% | 5.7% |
| Net Margin | 6.5% | 31.9% |
| Revenue YoY | 16.6% | 3.8% |
| Net Profit YoY | 104.3% | 236.9% |
| EPS (diluted) | $0.03 | $2.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $256.5M | ||
| Q4 25 | $270.3M | $-140.0M | ||
| Q3 25 | $237.5M | $269.3M | ||
| Q2 25 | $240.4M | $274.8M | ||
| Q1 25 | $223.8M | $241.7M | ||
| Q4 24 | $231.8M | $-66.2M | ||
| Q3 24 | $225.8M | $229.4M | ||
| Q2 24 | $266.6M | $240.5M |
| Q1 26 | — | $81.7M | ||
| Q4 25 | $17.6M | $81.7M | ||
| Q3 25 | $-77.7M | $9.3M | ||
| Q2 25 | $-98.4M | $16.7M | ||
| Q1 25 | $-118.3M | $12.4M | ||
| Q4 24 | $-412.3M | $5.6M | ||
| Q3 24 | $-801.2M | $2.5M | ||
| Q2 24 | $-320.6M | $10.9M |
| Q1 26 | — | 12.8% | ||
| Q4 25 | 95.8% | — | ||
| Q3 25 | — | 12.8% | ||
| Q2 25 | 91.8% | 13.8% | ||
| Q1 25 | 63.6% | 13.6% | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 96.5% | 15.4% | ||
| Q2 24 | 98.4% | 14.4% |
| Q1 26 | — | 5.7% | ||
| Q4 25 | 9.7% | — | ||
| Q3 25 | -28.0% | 6.2% | ||
| Q2 25 | -36.7% | 9.9% | ||
| Q1 25 | -48.5% | 9.0% | ||
| Q4 24 | -173.7% | — | ||
| Q3 24 | -350.7% | 3.6% | ||
| Q2 24 | -114.5% | 7.4% |
| Q1 26 | — | 31.9% | ||
| Q4 25 | 6.5% | -58.4% | ||
| Q3 25 | -32.7% | 3.5% | ||
| Q2 25 | -40.9% | 6.1% | ||
| Q1 25 | -52.8% | 5.1% | ||
| Q4 24 | -177.8% | -8.5% | ||
| Q3 24 | -354.8% | 1.1% | ||
| Q2 24 | -120.3% | 4.5% |
| Q1 26 | — | $2.03 | ||
| Q4 25 | $0.03 | $2.01 | ||
| Q3 25 | $-0.13 | $0.23 | ||
| Q2 25 | $-0.16 | $0.41 | ||
| Q1 25 | $-0.20 | $0.30 | ||
| Q4 24 | $-0.68 | $0.14 | ||
| Q3 24 | $-1.34 | $0.06 | ||
| Q2 24 | $-0.54 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $540.9M | $30.0M |
| Total DebtLower is stronger | $9.7B | — |
| Stockholders' EquityBook value | $4.6B | $705.6M |
| Total Assets | $15.0B | $1.5B |
| Debt / EquityLower = less leverage | 2.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $30.0M | ||
| Q4 25 | $540.9M | $30.0M | ||
| Q3 25 | $396.6M | $33.6M | ||
| Q2 25 | $509.8M | $30.3M | ||
| Q1 25 | $673.5M | $32.7M | ||
| Q4 24 | $332.3M | $23.1M | ||
| Q3 24 | $275.6M | $26.9M | ||
| Q2 24 | $606.5M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | $9.7B | $469.2M | ||
| Q3 25 | $9.6B | $407.1M | ||
| Q2 25 | $9.6B | $424.5M | ||
| Q1 25 | $9.5B | $434.2M | ||
| Q4 24 | $8.8B | $398.1M | ||
| Q3 24 | $9.2B | $409.9M | ||
| Q2 24 | $9.4B | $427.4M |
| Q1 26 | — | $705.6M | ||
| Q4 25 | $4.6B | $705.6M | ||
| Q3 25 | $4.7B | $725.0M | ||
| Q2 25 | $4.8B | $715.3M | ||
| Q1 25 | $4.8B | $686.6M | ||
| Q4 24 | $4.8B | $667.3M | ||
| Q3 24 | $5.4B | $682.8M | ||
| Q2 24 | $6.2B | $675.9M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $15.0B | $1.5B | ||
| Q3 25 | $14.9B | $1.4B | ||
| Q2 25 | $15.2B | $1.4B | ||
| Q1 25 | $14.9B | $1.4B | ||
| Q4 24 | $14.3B | $1.3B | ||
| Q3 24 | $15.2B | $1.4B | ||
| Q2 24 | $16.2B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | 2.11× | 0.66× | ||
| Q3 25 | 2.06× | 0.56× | ||
| Q2 25 | 2.00× | 0.59× | ||
| Q1 25 | 1.99× | 0.63× | ||
| Q4 24 | 1.83× | 0.60× | ||
| Q3 24 | 1.69× | 0.60× | ||
| Q2 24 | 1.51× | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.8M | $117.5M |
| Free Cash FlowOCF − Capex | — | $36.8M |
| FCF MarginFCF / Revenue | — | 14.4% |
| Capex IntensityCapex / Revenue | — | 18.9% |
| Cash ConversionOCF / Net Profit | 13.11× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | $109.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $117.5M | ||
| Q4 25 | $230.8M | $41.5M | ||
| Q3 25 | $18.6M | $36.5M | ||
| Q2 25 | $51.7M | $30.3M | ||
| Q1 25 | $384.0K | $9.2M | ||
| Q4 24 | $245.5M | $27.1M | ||
| Q3 24 | $59.2M | $22.0M | ||
| Q2 24 | $35.3M | $18.4M |
| Q1 26 | — | $36.8M | ||
| Q4 25 | — | $36.8M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | — | $-3.8M | ||
| Q4 24 | — | $12.1M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | — | $7.5M |
| Q1 26 | — | 14.4% | ||
| Q4 25 | — | -26.3% | ||
| Q3 25 | — | 8.5% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | -1.6% | ||
| Q4 24 | — | -18.3% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | — | 3.1% |
| Q1 26 | — | 18.9% | ||
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | -22.6% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | 1.44× | ||
| Q4 25 | 13.11× | 0.51× | ||
| Q3 25 | — | 3.92× | ||
| Q2 25 | — | 1.81× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | — | 8.71× | ||
| Q2 24 | — | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
